Jupiter Research Capital (Asia) Ltd’s BridgeBio Pharma BBIO Stock Holding History
Bought
Maintained
Sold
Other funds holding BBIO
Jupiter Research Capital (Asia) Ltd's BBIO Position: Q3 2026 in Review
Jupiter Research Capital (Asia) Ltd sold out of BridgeBio Pharma (BBIO) in Q3 2026, closing a stake of 177,863 shares — an estimated $13.2M sold.
Jupiter Research Capital (Asia) Ltd first reported a position in BBIO in Q2 2026 and held it in 1 quarter. The position peaked at $13.2M in Q2 2026. 428 funds tracked by Wall St. Rank hold BBIO as of Q3 2026.
- Jupiter Research Capital (Asia) Ltd reported no remaining BridgeBio Pharma position as of Q3 2026 after selling out during the quarter.
- Jupiter Research Capital (Asia) Ltd sold 177,863 BridgeBio Pharma shares in Q3 2026, an estimated $13.2M.
- Jupiter Research Capital (Asia) Ltd first reported a position in BridgeBio Pharma in Q2 2026 and held it in 1 quarter.
- Jupiter Research Capital (Asia) Ltd's BridgeBio Pharma position peaked at $13.2M in Q2 2026.
- 428 funds tracked by Wall St. Rank held BridgeBio Pharma as of Q3 2026.
Based on Jupiter Research Capital (Asia) Ltd's 13F filing for Q3 2026, filed 16 Nov 2026.